CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (10,287,300)	$ (4,839,585)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	632,121	449,183
Share-based compensation	659,250	295,305
Bad debt expense	4,266,013	1,506,654
Amortization of deferred financing costs and debt discount	23,072	0
Changes in operating assets and liabilities:
Accounts receivable	(4,890,804)	(3,052,701)
Prepaid expenses and other current assets	(15,069)	34,956
Accounts payable	(295,289)	(107,824)
Accrued expenses	(116,841)	174,908
Accrued royalties	(123,954)	457,086
Accrued payroll and related liabilities	(432,499)	102,216
Deferred revenue	0	(483,052)
Net cash used in operating activities	(10,581,300)	(5,462,854)
Cash flows from investing activities:
Purchases of property and equipment	(31,620)	(241,910)
Purchases of software	(54,132)	(137,499)
Cash paid for purchase of assets	0	(200,000)
Net cash used in investing activities	(85,752)	(579,409)
Cash flows from financing activities:
Net proceeds from issuance of debt	8,113,887	0
Net proceeds from issuance of common stock	0	1,702,271
Borrowing on line of credit	500,000	0
Capital lease payments	(137,779)	(133,410)
Proceeds from exercise of stock options	23,200	23,993
Net cash provided by financing activities	8,499,308	1,592,854
Effect of foreign exchange rates on cash and cash equivalents	(21,541)	(2,568)
Net decrease in cash and cash equivalents	(2,189,285)	(4,451,977)
Cash and cash equivalents:
Beginning of period	8,148,599	9,041,478
End of period	5,959,314	4,589,501
Cash paid during the period for:
Interest	80,552	65,949
Supplemental disclosure of non-cash financing activities
Equipment and software acquired under capital leases	61,317	239,150
Assets acquired by issuance of common stock	$ 0	$ 980,000